Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.

Milosevic D, Mills JR, Campion MB, Vidal-Folch N, Voss JS, Halling KC, Highsmith WE, Liu MC, Kipp BR, Grebe SKG.

Clin Chem. 2018 Dec;64(12):1732-1742. doi: 10.1373/clinchem.2018.291278. Epub 2018 Sep 20.

PMID:
30237149
2.

Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors.

Winters JL, Davila JI, McDonald AM, Nair AA, Fadra N, Wehrs RN, Thomas BC, Balcom JR, Jin L, Wu X, Voss JS, Klee EW, Oliver GR, Graham RP, Neff JL, Rumilla KM, Aypar U, Kipp BR, Jenkins RB, Jen J, Halling KC.

J Mol Diagn. 2018 Jul;20(4):495-511. doi: 10.1016/j.jmoldx.2018.03.007. Epub 2018 Jun 19.

3.

Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic Adenocarcinomas.

Levy MJ, Kipp BR, Milosevic D, Schneider AR, Voss JS, Avula R, Kerr SE, Henry MR, Highsmith E Jr, Liu MC, Gleeson FC.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1632-1640.e1. doi: 10.1016/j.cgh.2018.02.048. Epub 2018 Mar 8.

PMID:
29526691
4.

Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.

Clay R, Kipp BR, Jenkins S, Karwoski RA, Maldonado F, Rajagopalan S, Voss JS, Bartholmai BJ, Aubry MC, Peikert T.

Sci Rep. 2017 Dec 15;7(1):17620. doi: 10.1038/s41598-017-17659-6.

5.

Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.

Gleeson FC, Voss JS, Kipp BR, Kerr SE, Van Arnam JS, Mills JR, Marcou CA, Schneider AR, Tu ZJ, Henry MR, Levy MJ.

Oncotarget. 2017 Jun 28;8(55):93464-93475. doi: 10.18632/oncotarget.18750. eCollection 2017 Nov 7.

6.

Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.

Boland JM, Maleszewski JJ, Wampfler JA, Voss JS, Kipp BR, Yang P, Yi ES.

Hum Pathol. 2018 Jan;71:8-19. doi: 10.1016/j.humpath.2017.08.002. Epub 2017 Aug 17.

PMID:
28823574
7.

Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story.

Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM.

Mod Pathol. 2017 Sep;30(9):1223-1233. doi: 10.1038/modpathol.2017.52. Epub 2017 Jun 23.

8.

Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism.

Vaubel RA, Kollmeyer TM, Caron AA, Barr Fritcher EG, Voss JS, Liang H, Jenkins RB, Giannini C, Kipp BR.

Acta Neuropathol. 2017 Aug;134(2):317-319. doi: 10.1007/s00401-017-1727-5. Epub 2017 May 26. No abstract available.

PMID:
28550371
9.

Non-V600 BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.

Jones JC, Renfro LA, Al-Shamsi HO, Schrock AB, Rankin A, Zhang BY, Kasi PM, Voss JS, Leal AD, Sun J, Ross J, Ali SM, Hubbard JM, Kipp BR, McWilliams RR, Kopetz S, Wolff RA, Grothey A.

J Clin Oncol. 2017 Aug 10;35(23):2624-2630. doi: 10.1200/JCO.2016.71.4394. Epub 2017 May 9.

10.

Ciliated Muconodular Papillary Tumors of the Lung Can Occur in Western Patients and Show Mutations in BRAF and AKT1.

Liu L, Aesif SW, Kipp BR, Voss JS, Daniel S, Aubry MC, Boland JM.

Am J Surg Pathol. 2016 Dec;40(12):1631-1636.

PMID:
27454941
11.

Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.

Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Graham RP, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ.

Oncotarget. 2016 Aug 23;7(34):54526-54536. doi: 10.18632/oncotarget.9440.

12.

Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.

Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ.

Gastrointest Endosc. 2016 Dec;84(6):950-958.e3. doi: 10.1016/j.gie.2016.04.027. Epub 2016 Apr 23.

PMID:
27118626
13.

Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.

Yamada S, Kipp BR, Voss JS, Giannini C, Raghunathan A.

Am J Surg Pathol. 2016 Feb;40(2):279-84. doi: 10.1097/PAS.0000000000000515.

PMID:
26414224
14.

An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.

Barr Fritcher EG, Voss JS, Brankley SM, Campion MB, Jenkins SM, Keeney ME, Henry MR, Kerr SM, Chaiteerakij R, Pestova EV, Clayton AC, Zhang J, Roberts LR, Gores GJ, Halling KC, Kipp BR.

Gastroenterology. 2015 Dec;149(7):1813-1824.e1. doi: 10.1053/j.gastro.2015.08.046. Epub 2015 Aug 29.

PMID:
26327129
15.

Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.

Kroneman TN, Voss JS, Lohse CM, Wu TT, Smyrk TC, Zhang L.

Endocr Pathol. 2015 Sep;26(3):255-62. doi: 10.1007/s12022-015-9379-2.

PMID:
26072124
16.

Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.

Brankley SM, Halling KC, Jenkins SM, Timmer MR, Iyer PG, Smyrk TC, Barr Fritcher EG, Voss JS, Kipp BR, Campion MB, Lutzke LS, Minot DM, Wang KK.

Dis Esophagus. 2016 Aug;29(6):513-9. doi: 10.1111/dote.12372. Epub 2015 Jun 5.

17.

Endoscopic ultrasound fine-needle aspiration cytology mutation profiling using targeted next-generation sequencing: personalized care for rectal cancer.

Gleeson FC, Kipp BR, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Sciallis AP, Graham RP, Lazaridis KN, Henry MR, Levy MJ.

Am J Clin Pathol. 2015 Jun;143(6):879-88. doi: 10.1309/AJCPU3J7FGAYQBRL.

PMID:
25972331
18.

Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph nodes in rectal cancer with theranostic potential.

Gleeson FC, Kipp BR, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Graham RP, Lazaridis KN, Henry MR, Levy MJ.

Gastrointest Endosc. 2015 Sep;82(3):550-6.e1. doi: 10.1016/j.gie.2015.01.050. Epub 2015 Apr 14.

PMID:
25887718
19.

Somatic STK11 and concomitant STK11/KRAS mutational frequency in stage IV lung adenocarcinoma adrenal metastases.

Gleeson FC, Kipp BR, Levy MJ, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Kerr SE.

J Thorac Oncol. 2015 Mar;10(3):531-4. doi: 10.1097/JTO.0000000000000391.

20.

Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.

Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar V, Sherman ME.

Gynecol Oncol. 2015 Apr;137(1):14-22. doi: 10.1016/j.ygyno.2015.01.552. Epub 2015 Feb 10.

21.

Diagnostic accuracy of bronchial brush cytology and the added value of immunohistochemistry and fluorescence in situ hybridization of pulmonary neuroendocrine tumors.

Reynolds JP, Voss JS, Brankley SM, Caudill JM, Henry MR, Clayton AC, Halling KC, Nassar A.

Cytojournal. 2014 Dec 3;11:32. doi: 10.4103/1742-6413.146120. eCollection 2014.

22.

Characterization of endoscopic ultrasound fine-needle aspiration cytology by targeted next-generation sequencing and theranostic potential.

Gleeson FC, Kipp BR, Kerr SE, Voss JS, Lazaridis KN, Katzka DA, Levy MJ.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):37-41. doi: 10.1016/j.cgh.2014.10.017. Epub 2014 Oct 24. Review.

PMID:
25424571
23.

Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.

Gleeson FC, Kipp BR, Levy MJ, Voss JS, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Kerr SE.

Cancer Cytopathol. 2014 Nov;122(11):822-32. doi: 10.1002/cncy.21464. Epub 2014 Jul 15.

24.

Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.

Kerr SE, Barr Fritcher EG, Campion MB, Voss JS, Kipp BR, Halling KC, Lewis JT.

Hum Pathol. 2014 Sep;45(9):1797-804. doi: 10.1016/j.humpath.2014.05.008. Epub 2014 Jun 4.

PMID:
25027853
25.

Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing.

Gleeson FC, Kipp BR, Kerr SE, Voss JS, Graham RP, Campion MB, Minot DM, Tu ZJ, Klee EW, Lazaridis KN, Henry MR, Levy MJ.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):202-6. doi: 10.1016/j.cgh.2014.06.024. Epub 2014 Jul 3.

PMID:
24997326
26.

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.

Kizilbash SH, Giannini C, Voss JS, Decker PA, Jenkins RB, Hardie J, Laack NN, Parney IF, Uhm JH, Buckner JC.

J Neurooncol. 2014 Oct;120(1):85-93. doi: 10.1007/s11060-014-1520-4. Epub 2014 Jul 4.

27.

An investigation into false-negative transthoracic fine needle aspiration and core biopsy specimens.

Minot DM, Gilman EA, Aubry MC, Voss JS, Van Epps SG, Tuve DJ, Sciallis AP, Henry MR, Salomao DR, Lee P, Carlson SK, Clayton AC.

Diagn Cytopathol. 2014 Dec;42(12):1063-8. doi: 10.1002/dc.23169. Epub 2014 May 28.

PMID:
24866385
28.

Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC.

Cancer Cytopathol. 2014 Jun;122(6):459-67. doi: 10.1002/cncy.21414. Epub 2014 Mar 6.

29.

Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.

Voss JS, Iqbal S, Jenkins SM, Henry MR, Clayton AC, Jett JR, Kipp BR, Halling KC, Maldonado F.

Hum Pathol. 2014 Jan;45(1):41-7. doi: 10.1016/j.humpath.2013.07.038. Epub 2013 Oct 16.

PMID:
24139213
30.

Systemic karyomegaly with primary pulmonary presentation.

Tagliente DJ, Voss JS, Peters SG, Aubry MC, Cornell LD, Maleszewski JJ.

Hum Pathol. 2014 Jan;45(1):180-4. doi: 10.1016/j.humpath.2013.07.036. Epub 2013 Sep 16.

PMID:
24047724
31.

Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Barr Fritcher EG, Voss JS, Jenkins SM, Lingineni RK, Clayton AC, Roberts LR, Halling KC, Talwalkar JA, Gores GJ, Kipp BR.

Cancer Cytopathol. 2013 Dec;121(12):708-17. doi: 10.1002/cncy.21331. Epub 2013 Jul 9.

32.

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.

Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR.

Hum Pathol. 2013 Jul;44(7):1216-22. doi: 10.1016/j.humpath.2012.11.006. Epub 2013 Feb 4.

PMID:
23391413
33.

Molecular diagnostics, personalized medicine, and the evolving role of the cytotechnologist: an institutional experience.

Kane LE, Root RR, Voss JS, Caudill JL, Sorenson AM, Colborn LK, Halling KC, Henry MR, Clayton AC, Kipp BR.

Acta Cytol. 2012;56(6):678-85. doi: 10.1159/000341169. Epub 2012 Nov 24.

PMID:
23207447
34.

Detection of lung cancer in bronchial brushing specimens by FISH.

Voss JS, Kipp BR, Halling KC.

Expert Rev Mol Diagn. 2012 Sep;12(7):679-81. doi: 10.1586/erm.12.69.

PMID:
23153235
35.

BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern.

Ida CM, Lambert SR, Rodriguez FJ, Voss JS, Mc Cann BE, Seys AR, Halling KC, Collins VP, Giannini C.

J Neuropathol Exp Neurol. 2012 Jul;71(7):631-9. doi: 10.1097/NEN.0b013e31825c448a.

PMID:
22710963
36.

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.

Kipp BR, Voss JS, Kerr SE, Barr Fritcher EG, Graham RP, Zhang L, Highsmith WE, Zhang J, Roberts LR, Gores GJ, Halling KC.

Hum Pathol. 2012 Oct;43(10):1552-8. doi: 10.1016/j.humpath.2011.12.007. Epub 2012 Apr 12.

PMID:
22503487
37.

Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.

Barr Fritcher EG, Kipp BR, Voss JS, Clayton AC, Lindor KD, Halling KC, Gores GJ.

Am J Gastroenterol. 2011 Nov;106(11):2023-8. doi: 10.1038/ajg.2011.272. Epub 2011 Aug 16.

PMID:
21844920
38.

Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.

Brankley SM, Fritcher EG, Smyrk TC, Keeney ME, Campion MB, Voss JS, Clayton AC, Wang KK, Lutzke LS, Kipp BR, Halling KC.

Hum Pathol. 2012 Feb;43(2):172-9. doi: 10.1016/j.humpath.2011.04.018. Epub 2011 Aug 4.

PMID:
21820152
39.

Evolution of transthoracic fine needle aspiration and core needle biopsy practice: A comparison of two time periods, 1996-1998 and 2003-2005.

Minot DM, Jaben E, Aubry MC, Voss JS, Vine RL, Lee PU, Carlson SK, Clayton AC.

Diagn Cytopathol. 2012 Oct;40(10):876-81. doi: 10.1002/dc.21666. Epub 2011 Mar 22.

PMID:
21433003
41.

Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens.

Voss JS, Kipp BR, Halling KC, Henry MR, Jett JR, Clayton AC, Rickman OB.

Am J Respir Crit Care Med. 2010 Mar 1;181(5):478-85. doi: 10.1164/rccm.200907-1121OC. Epub 2009 Dec 10.

PMID:
20007925
42.

Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens.

Voss JS, Kipp BR, Campion MB, Sokolova IA, Henry MR, Halling KC, Clayton AC.

Anal Quant Cytol Histol. 2009 Aug;31(4):208-16.

PMID:
19736868
43.

Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.

Kipp BR, Tyner HL, Campion MB, Voss JS, Karnes RJ, Sebo TJ, Halling KC, Zhang J.

Am J Clin Pathol. 2008 Oct;130(4):552-9. doi: 10.1309/DFJUHY3WPC9GUU2W.

PMID:
18794047
44.

Changes in specimen preparation method may impact urine cytologic evaluation.

Voss JS, Kipp BR, Krueger AK, Clayton AC, Halling KC, Karnes RJ, Henry MR, Sebo TJ.

Am J Clin Pathol. 2008 Sep;130(3):428-33. doi: 10.1309/VP1XQ5GPQ687W1HU.

PMID:
18701417
45.

A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.

Fritcher EG, Brankley SM, Kipp BR, Voss JS, Campion MB, Morrison LE, Legator MS, Lutzke LS, Wang KK, Sebo TJ, Halling KC.

Hum Pathol. 2008 Aug;39(8):1128-35. doi: 10.1016/j.humpath.2008.02.003. Epub 2008 Jul 7.

46.

Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens.

Sokolova I, Algeciras-Schimnich A, Song M, Sitailo S, Policht F, Kipp BR, Voss JS, Halling KC, Ruth A, King W, Underwood D, Brainard J, Morrison L.

J Mol Diagn. 2007 Nov;9(5):604-11. Erratum in: J Mol Diagn. 2008 Jan;10(1):109.

Supplemental Content

Support Center